{"id":"W2136517791","doi":"10.1016/j.jaad.2015.04.011","title":"Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":206,"is_retracted":false,"has_abstract":false,"ca_institutions":"XLV Diagnostics (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Secukinumab; Plaque psoriasis; Randomized controlled trial; Regimen; Double blind; Psoriasis; Dermatology; Surgery; Placebo; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001448077,0.001902545,0.003891341,0.0005339419,0.0005004522,0.001266715,0.001189394,0.001827945,0.009019819],"category_scores_gemma":[0.001352068,0.0007526991,0.002162685,0.0004642807,0.001415569,0.001546088,0.0004301578,0.004294565,0.001445286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006172053,"about_ca_system_score_gemma":0.000725569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001143025,"about_ca_topic_score_gemma":0.002397739,"domain_scores_codex":[0.9995062,0.0002145332,0.00002825836,0.0001093656,0.00003942474,0.0001021707],"domain_scores_gemma":[0.999424,0.0001550597,0.0001133144,0.0000681867,0.00003342074,0.0002060415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9815886,0.003024168,0.0002244272,0.000467725,0.0006234722,0.00002115849,0.00003009551,0.00024487,0.001544828,0.00009531608,0.0005924909,0.01154278],"study_design_scores_gemma":[0.973216,0.02488902,0.0007862131,0.0000202317,0.0002606583,0.00001746711,0.00001481106,0.0003371782,0.00016154,0.00009216147,0.0001944171,0.00001035807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985015,0.005664319,0.0009954958,0.0008059073,0.001067736,0.002395023,0.001065331,0.0003435732,0.002647807],"genre_scores_gemma":[0.9854391,0.003052063,0.001645664,0.001096348,0.0006473489,0.00243375,0.0008923861,0.00004910928,0.004744242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009019819,"threshold_uncertainty_score":0.03017431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0436581266930141,"score_gpt":0.3196616556641326,"score_spread":0.2760035289711185,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}